11 years' follow-up of trastuzumab after adjuvant...

The Lancet 2017 / 03 Vol. 389; Iss. 10075

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

Cameron, David, Piccart-Gebhart, Martine J, Gelber, Richard D, Procter, Marion, Goldhirsch, Aron, de Azambuja, Evandro, Castro, Gilberto, Untch, Michael, Smith, Ian, Gianni, Luca, Baselga, Jose, Al-Sa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
389
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(16)32616-2
Date:
March, 2017
File:
PDF, 601 KB
english, 2017
Conversion to is in progress
Conversion to is failed